Brett A. Pletcher - 10 Mar 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Signature
/s/ Amy Kim by Power of Attorney for Brett A. Pletcher
Issuer symbol
GILD
Transactions as of
10 Mar 2022
Net transactions value
-$332,639
Form type
4
Filing time
14 Mar 2022, 21:46:01 UTC
Previous filing
13 Apr 2022
Next filing
13 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +2,593 +8% 35,169 10 Mar 2022 Direct F1
transaction GILD Common Stock Options Exercise +3,130 +8.9% 38,299 10 Mar 2022 Direct F1
transaction GILD Common Stock Tax liability $120,995 -2,089 -5.5% $57.92 36,210 10 Mar 2022 Direct
transaction GILD Common Stock Sale $211,644 -3,634 -10% $58.24 32,576 11 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -2,593 -11% 20,431 10 Mar 2022 Common Stock 2,593 Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -3,130 -15% 17,301 10 Mar 2022 Common Stock 3,130 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.